Lessons from radiochemotherapy and modern image-guided adaptive brachytherapy followed by hysterectomy

Archive ouverte

Varela Cagetti, Leonel | Zemmour, Christophe | Minsat, Mathieu | Lambaudie, Eric | Houvenaeghel, Gilles | Provansal, Magalie | Cappiello, Marie-Antoniette | Rua, Sandrine | Jauffret, Camille | Ferré, Marjorie | Mailleux, Hugues | Gonzague, Laurence | Tallet, Agnès

Edité par CCSD ; Elsevier -

International audience. Purpose: To analyze the clinical outcomes and the safety of radiochemotherapy (RCT) and image-guided adaptive brachytherapy (IGABT) and to evaluate the impact of hysterectomy (HT) as completion of treatment for cervical cancer.Methods and materials: 145 patients with locally advanced cervical cancer were treated at our institution. Patients underwent RCT and IGABT, then hysterectomy (HT) as completion of treatment was performed, with the exception of patients with surgical contraindications, para aortic metastatic disease or patients who refused surgery. Clinical outcomes and morbidity were retrospectively reviewed in both groups. Local relapse free survival (LRFS), pelvic relapse free survival (PRFS) and overall survival (OS) were analyzed.Results: Completion HT was performed in 90 (62.1%) patients. Complete histological response and microscopic disease were found in 77 patients (85.6%). Local relapse was observed in 14 patients (9.6%) without differences between completion HT group and the definitive RCT and IGABT group (Odds Ratio OR = 1.73 [0.57-5.23], p = 0.33). The estimated 3-year LRFS and PRFS for the entire population were respectively 90% [84%-94%] and 93% [87%-96%], with no significant differences between them (respectively Hazard Ratio HR = 0.57 [0.20-1.64], p = 0.30 and HR = 0.37 [0.10-1.31], p = 0.12). The estimated 3-year OS rate for the whole population was 84% [75%-91%] with no significant differences between groups (HR = 0.81 [0.32-2.06], p = 0.65). Regarding morbidity, grade ≥ 2 vaginal toxicity was more frequent in the definitive RCT and IGABT group (43.6% vs 26.7%, p = 0.04). All grade 4 toxicity events were reported in the completion HT group.Conclusions: Due to high severe toxicity, RCT and IGABT with dose escalation followed by completion hysterectomy don't seem compatible. No benefit and increased severe late morbidity were observed. Combined intracavitary/interstitial technique is mandatory in large target volume at brachytherapy.

Suggestions

Du même auteur

The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer

Archive ouverte | Varela Cagetti, Leonel | CCSD

International audience. Purpose: To analyze the clinical outcomes and the safety of preoperative high-dose-rate (HDR) image-guided adaptive brachytherapy (IGABT) followed by minimally invasive surgery (MIS) in the m...

Early clinical outcomes of hybrid brachytherapy for locally advanced cervical cancer: making adverse situations in a favorable scenario

Archive ouverte | Cagetti, Leonel, Varela | CCSD

International audience. Purpose: To investigate the feasibility and early clinical outcomes of combined intra-cavitary (IC) and interstitial (IS) image-guided adaptive brachytherapy (IGABT) as curative and definitiv...

Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancer

Archive ouverte | Annede, Pierre | CCSD

International audience. PURPOSE:To explore the best variables combination for a predictive model of vaginal toxicity in cervical cancer patients undergoing brachytherapy (BT).METHODS AND MATERIALS:Clinical and 3-dim...

Chargement des enrichissements...